Taylor Morrison Home (TMHC) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
8 Jul, 2026Executive summary
Delivered 3,340 homes in Q2 2025 at an average price of $589,000, generating $2.03 billion in revenue, a 2% year-over-year increase, with adjusted home closings gross margin at 23%.
Net income for Q2 was $194 million ($1.92 per diluted share); adjusted net income was $204 million ($2.02 per diluted share), reflecting strong operational execution.
Spec sales reached a record 71% of total sales, driven by consumer preference for incentives and quick move-in options.
Net sales orders declined 12% year-over-year, with a 2.6 monthly absorption pace and a 14.6% cancellation rate, up from 9.4%.
Performance met or exceeded guidance on most key metrics, supported by a diversified product portfolio and balanced strategy.
Financial highlights
Adjusted home closings gross margin was 23.0%; GAAP gross margin was 22.3%, both down year-over-year.
SG&A expense as a percentage of revenue improved by 90 basis points year-over-year to 9.3%.
Net homebuilding debt to capitalization ratio at 22.9%; gross homebuilding debt to capital ratio at 24.2%.
Total liquidity was $1.1 billion, including $130 million cash and $952 million available on revolver.
Financial services revenue was $53 million with a gross margin of 51.1%.
Outlook and guidance
Full-year 2025 home closings expected between 13,000 and 13,500, with an average closing price of $595,000–$600,000.
Adjusted home closings gross margin guidance at approximately 23% for the year; GAAP gross margin expected near 22.5%.
Q3 2025 home closings expected between 3,200–3,300, average closing price around $600,000, and GAAP gross margin near 22%.
SG&A as a percentage of home closings revenue projected in the mid-9% range.
At least $350 million in share repurchases planned for 2025.
Latest events from Taylor Morrison Home
- Q3 2025 saw $2.0B revenue, $201M net income, and 22.1% gross margin with strong liquidity.TMHC
Q3 20259 Jul 2026 - Aims for 20,000 closings by 2028 with digital innovation, capital discipline, and high-teen ROE.TMHC
Investor Day 20258 Jul 2026 - Q3 net income up 54% to $251M, with strong revenue, margin gains, and robust guidance.TMHC
Q3 20248 Jul 2026 - Q2 2024 delivered 3,200 closings, raised guidance, and maintained strong liquidity.TMHC
Q2 20248 Jul 2026 - Stockholders to vote on $72.50/share cash merger with Berkshire Hathaway, board recommends approval.TMHC
Proxy filing23 Jun 2026 - Shareholders to vote on Berkshire Hathaway's $72.50 per share all-cash acquisition, with board support.TMHC
Proxy filing12 Jun 2026 - Taylor Morrison to be acquired by Berkshire Hathaway, pending shareholder approval.TMHC
Proxy filing12 Jun 2026 - Definitive acquisition agreement reached; shareholders to vote, with no immediate business changes.TMHC
Proxy filing5 Jun 2026 - Definitive agreement for acquisition by Berkshire Hathaway, pending shareholder approval.TMHC
Proxy filing5 Jun 2026